Effects of contraceptives on hemoglobin and ferritin

Contraception

Volumn 58, Issue 5, 1998, Pages 261-273

  Bathija, H ^a   Lei, Z W ^a   Cheng, X Q ^a   Xie, L ^a   Wang, Y ^a   Rugpao, S ^a   Lipisam, S ^a   Suwanarach, C ^a   Akhter, H ^a   Ahmed, Y ^a   Islam, Z ^a   Sen, A ^a   Bahman, S ^a   Khan, S A ^a   Rabbani, A ^a   Khan, T ^a   Sued, E M ^a   Lumbiganon, P ^a   Weerawattrakul, Y ^a   Pinitsoontorn, P ^a   Bierschwale, H ^a   Silva, P ^a   Bravo, C ^a   Gajardo, R ^a   Meta, N ^a   Lavin, F ^a   Tuane, R ^a   Chong, E ^a   Hajri, S ^a   Siala, N ^a   Bessioud, M ^a   Boukhris, R ^a   more..

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Anemia; Copper intrauterine device; Depot medroxyprogesterone acetate (DMPA); Ferritin; Hemoglobin; Norplant implants; Oral contraceptives; Stainless steel intrauterine device

Indexed keywords

COPPER INTRAUTERINE DEVICE; DESOGESTREL PLUS ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORETHISTERONE; ETHINYLESTRADIOL PLUS NORGESTREL; FERRITIN; HEMOGLOBIN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MULTILOAD COPPER INTRAUTERINE DEVICE; ORAL CONTRACEPTIVE AGENT; STAINLESS STEEL;

ADULT; ARTICLE; BANGLADESH; CHILE; CHINA; CLINICAL TRIAL; DOMINICAN REPUBLIC; DRUG EFFECT; DRUG IMPLANT; FEMALE; FERRITIN BLOOD LEVEL; HORMONAL CONTRACEPTION; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAUTERINE CONTRACEPTIVE DEVICE; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; PAKISTAN; SUBCUTANEOUS DRUG ADMINISTRATION; THAILAND; TUNISIA;

EID: 0032412251     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(98)00108-5     Document Type: Article

References (37)

1. The Prevalence of Anaemia in Women A Tabulation of Available Information, Second Edition . 1992;World Health Organization, Geneva.
2. Sloan NL, Jordan EA. The prevalence of maternal anaemia in developing countries. Working papers 7A and 7B. Arlington, VA: Mother Care Project, John Snow, Inc., April 1992.
3. Cohen B.J.B., Gibor Y. Anaemia and menstrual blood loss. Obstet Gynecol Surv. 35:1980;597-618.
4. Addison G., Beamish M.R., Hales C.N., Hodgkins M., Jacobs A., Llewellin P. An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overload. J Clin Pathol. 25:1972;326-329.
5. Lipschitz D.A., Cook J.D., Finch C.A. A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med. 290:1974;1213-1216.
6. Cook J.D., Lipschitz D.A., Miles L.M., Finch C.A. Serum ferritin as a measure of iron stores in normal subjects. Am J Clin Nutr. 27:1974;681-687.
7. Jacobs A., Path F., Worwood M. Ferritin in serum Clinical and biochemical implications . N Engl J Med. 1975;951-956.
8. World Health Organization. Recommended method for the determination of the haemoglobin concentration of blood. Prepared on behalf of the World Health Organization by OW van Assendelft, AH Holtz and SM Lewis in cooperation with the Expert Panel on Haemoglobinometry of the International Committee for Standardization in Haematology. Revised 1984.
9. Fleiss J.L. The Design and Analysis of Clinical Experiments. 1986;John Wiley and Sons, New York.
10. Fleiss J.L. Analysis of data from multiclinic trials. Control Clin Trials. 7:1986;267-275.
11. Kim I., Yetley E.A., Calvo M.S. Variations in iron-status measures during the menstrual cycle. Am J Clin Nutr. 58:1993;705-709.
12. Fricker J., Le Moel G., Apfelbaum M. Obesity and iron status in menstruating women. Am J Clin Nutr. 52:1990;863-866.
13. Rivera R., Almonte H., Arreola M., et al. The effects of three different regimens of oral contraceptives and three different intrauterine devices on the levels of hemoglobin, serum iron and iron binding capacity in anemic women. Contraception. 27:1983;311-327.
14. Sloan NL, Jordan EA, Winikoff B. Does iron supplementation make a difference? Arlington, VA: Mother Care Project, John Snow, Inc., 1992.
15. Frassinelli-Gunderson E.P., Sheldon M., Brown J. Iron stores in users of oral contraceptive agents. Am J Clin Nutr. 41:1985;703-712.
16. Milman N., Kirchhoff M., Jorgensen T. Iron status markers, serum ferritin and hemoglobin in 1359 Danish women in relation to menstruation, hormonal contraception, parity, and postmenopausal hormone treatment. Ann Hematol. 65:1992;96-102.
17. Massé P.G., Roberge A.G. Long-term effect of low-dose combined steroid contraceptives on body iron status. Contraception. 46:1992;243-252.
18. Larsson G., Milsom I., Lindstedt G., Rybo G. The influence of a low-dose combined oral contraceptive on menstrual blood loss and iron status. Contraception. 46:1992;327-334.
19. Mardell M., Symmons C., Zilva J. A comparison of the effect of oral contraceptives, pregnancy and sex on iron metabolism. J Clin Endocrinol. 29:1969;1489-1495.
20. Godsland I., Seed M., Simpson R., Broom G., Wynn V. Comparison of haematological indices between women of four ethnic groups and the effect of oral contraceptives. J Clin Pathol. 36:1983;184-191.
21. Ghoneim S.M., Toppozada H.K., El-Heneidy A.R., Tana M.M. The effect of an oral contraceptive on acid-base balance, blood gases, and electrolytes. Contraception. 12:1975;395-406.
22. d'Arcangues C., Odlind V., Fraser I.S. Dysfunctional uterine bleeding induced by exogenous hormones. Alexander N.J., d'Arcangues C. Steroid Hormones and Uterine Bleeding. 1992;81-105 American Association for the Advancement of Science, Washington, DC.
23. Faundes A., Tejada A.S., Brache V., Alvarez F. Subjective perception of bleeding and serum ferritin concentration in long-term users of Norplant. Contraception. 35:1987;189-196.
24. Fakeye O., Balogh S. Effect of Norplant contraceptive use on hemoglobin, packed cell volume and menstrual bleeding patterns. Contraception. 39:1989;265-274.
25. Gu S., Du M.G., Yuan D.Y., et al. A two-year study of acceptability, side effects, and effectiveness of Norplant and Norplant-2 implants in the People's Republic of China. Contraception. 38:1988;641-657.
26. Du M., Zheng H., Chen H., Chow L. Study of Norplant implants in Shanghai Three-year experience . Int J Gynecol Obstet. 33:1990;345-357.
27. Olsson S., Odlind V., Johansson E., Sivin I. Contraception with Norplant implants and Norplant-2 implants (two covered rods) Results from a comparative clinical study in Sweden . Contraception. 37:1988;61-73.
28. Consequences of uterine blood loss caused by various intrauterine contraceptive devices in South American women. Contraception. 38:1988;1-18.
29. Larsson G., Milsom I., Jonasson K., Lindstedt G., Rybo G. The long-term effects of copper surface area on menstrual blood loss and iron status in women fitted with an IUD. Contraception. 48:1993;471-480.
30. Guillebaud J., Bonnar J., Morehead J., Matthew A. Menstrual blood loss with intrauterine devices. Lancet. i:1976;387-390.
31. Gao J., Zeng S., Sun B., et al. Menstrual blood loss, hemoglobin and ferritin concentration of Beijing women wearing steel ring, VCu200, and TCu220c IUD. Contraception. 34:1986;559-571.
32. Blum M., Ariel J., Zacharowitch D. Ferritin, a faithful reflection of iron deficiency in IUD wearers with mild vaginal spotting. Adv Contracept. 7:1991;39-42.
33. Kivijärvi A., Timonen H., Rajamäki A., Grönroos M. Iron deficiency in women using modern copper intrauterine devices. Obstet Gynecol. 67:1986;95-98.
34. Guillebaud J., Barnett M.D., Gordon Y.B. Plasma ferritin levels as an index of iron deficiency in women using intrauterine devices. Br J Obstet Gynecol. 86:1979;51-55.
35. Faguer C. Etude et intérêt du dosage de la ferritine chez 104 utilisatrices de stérilet. (in French) J Gynecol Obstet Biol Reprod. 23:1994;141-144.
36. Johnson W.D., George V.T. Effect of regression to the mean in the presence of within-subject variability. Stats Med. 10:1991;1295-1302.
37. Improving Access to Quality Care in Family Planning. Medical Eligibility Criteria for Initiating and Continuing Use of Contraceptive Methods. 1996;World Health Organization, Geneva.